Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company and its Chinese partner have announced the launch of a joint project to build a new facility. The plant will be located in the Irkutsk region and will focus on the production of pharmaceutical substances necessary for creating medicinal drugs.
The total cost of the project is estimated at 13.06 billion tenge. Investments will be directed toward purchasing modern equipment, constructing production workshops, and creating the necessary infrastructure. It is expected that the new enterprise will help strengthen the region's pharmaceutical security and reduce dependence on imported components.
Cooperation with Chinese partners will allow for the use of advanced technologies in the fields of chemistry and medicine. Experts note that establishing such production facilities within the country is an important step for the development of the Russian pharmaceutical industry. This will enable the manufacturing of high-quality medicines at more affordable prices.
The launch of the plant is planned for the coming years. The project will not only create new jobs for residents of the Irkutsk region but will also serve as an important example of international cooperation in the spheres of healthcare and high technology.